Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Bausch Health Companies stock

Own Bausch Health Companies stock in just a few minutes.

Bausch Health Companies Inc is a drug manufacturers-specialty & generic business based in the US. Bausch Health Companies shares (BHC) are listed on the NYSE and all prices are listed in US Dollars. Bausch Health Companies employs 21,600 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Bausch Health Companies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BHC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Bausch Health Companies share price

Use our graph to track the performance of BHC stocks over time.

Bausch Health Companies shares at a glance

Information last updated 2021-04-29.
52-week range$14.86 - $34.80
50-day moving average $31.33
200-day moving average $25.16
Wall St. target price$35.56
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.61

Buy Bausch Health Companies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Bausch Health Companies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Bausch Health Companies under- or over-valued?

Valuing Bausch Health Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bausch Health Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bausch Health Companies's EBITDA

Bausch Health Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.

The EBITDA is a measure of a Bausch Health Companies's overall financial performance and is widely used to measure a its profitability.

Bausch Health Companies financials

Revenue TTM $8 billion
Operating margin TTM 16.62%
Gross profit TTM $5.8 billion
Return on assets TTM 2.56%
Return on equity TTM -64.22%
Profit margin -6.98%
Book value $1.51
Market capitalisation $11.4 billion

TTM: trailing 12 months

Shorting Bausch Health Companies shares

There are currently 15.7 million Bausch Health Companies shares held short by investors – that's known as Bausch Health Companies's "short interest". This figure is 5.1% up from 15.0 million last month.

There are a few different ways that this level of interest in shorting Bausch Health Companies shares can be evaluated.

Bausch Health Companies's "short interest ratio" (SIR)

Bausch Health Companies's "short interest ratio" (SIR) is the quantity of Bausch Health Companies shares currently shorted divided by the average quantity of Bausch Health Companies shares traded daily (recently around 4.0 million). Bausch Health Companies's SIR currently stands at 3.97. In other words for every 100,000 Bausch Health Companies shares traded daily on the market, roughly 3970 shares are currently held short.

However Bausch Health Companies's short interest can also be evaluated against the total number of Bausch Health Companies shares, or, against the total number of tradable Bausch Health Companies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bausch Health Companies's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Bausch Health Companies shares in existence, roughly 40 shares are currently held short) or 0.0507% of the tradable shares (for every 100,000 tradable Bausch Health Companies shares, roughly 51 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bausch Health Companies.

Find out more about how you can short Bausch Health Companies stock.

Bausch Health Companies's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bausch Health Companies.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Bausch Health Companies's total ESG risk score

Total ESG risk: 41.19

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bausch Health Companies's overall score of 41.19 (as at 12/31/2018) is pretty weak – landing it in it in the 89th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Bausch Health Companies is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Bausch Health Companies's environmental score

Environmental score: 3.36/100

Bausch Health Companies's environmental score of 3.36 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Bausch Health Companies's social score

Social score: 23.99/100

Bausch Health Companies's social score of 23.99 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Bausch Health Companies is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Bausch Health Companies's governance score

Governance score: 16.84/100

Bausch Health Companies's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Bausch Health Companies is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Bausch Health Companies's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Bausch Health Companies scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Bausch Health Companies has a damaged public profile.

Environmental, social, and governance (ESG) summary

Bausch Health Companies Inc was last rated for ESG on: 2019-01-01.

Total ESG score 41.19
Total ESG percentile 88.8
Environmental score 3.36
Environmental score percentile 4
Social score 23.99
Social score percentile 4
Governance score 16.84
Governance score percentile 4
Level of controversy 4

Bausch Health Companies share dividends

We're not expecting Bausch Health Companies to pay a dividend over the next 12 months.

Have Bausch Health Companies's shares ever split?

Bausch Health Companies's shares were split on a 2:1 basis on 15 October 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bausch Health Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bausch Health Companies shares which in turn could have impacted Bausch Health Companies's share price.

Bausch Health Companies share price volatility

Over the last 12 months, Bausch Health Companies's shares have ranged in value from as little as $14.86 up to $34.8. A popular way to gauge a stock's volatility is its "beta".

BHC.US volatility(beta: 1.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bausch Health Companies's is 1.7292. This would suggest that Bausch Health Companies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Bausch Health Companies overview

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site